Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 — Sioux City, Iowa

Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 is a clinical research site located in Sioux City, Iowa, United States 51101.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS).

Sponsors: RECORDATI GROUP.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220?

Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 conducted?

Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 has 1 clinical trials on record, with 1 currently active. Their work covers Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS).

Is Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 accredited by Crixeo Health?

Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Siouxland Regional Cancer Center dba June E. Nylen Cancer Center Site Number : 1220?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.